BLB develops analysis with highly pure and viable rodent and human primary hepatocytes, liver sinusoidal endothelial cells, hepatic stellate cells and Kupffer cells
Cells are routinely isolated and experiments performed shortly after their separation, allowing proper analysis in non de-differentiated cells. BLB performs analysis in hepatic cells isolated from healthy individuals and, importantly, from livers with cirrhosis (ASH and NASH aetiologies). Primary liver cells can be used to understand the effects of your new chemical compounds on cells phenotype.
Ask us about the wide variety of wide variety of molecular and functional markersthat can be determined.
The complete pre-clinical Solution
BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.
BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers